Novavax, Inc. Reports Third-Quarter 2012 Financial Results

November 2, 2012 |

1 min read

ROCKVILLE, Md., Nov. 2, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the third quarter and nine months ended September 30, 2012.

Earnings

MORE ON THIS TOPIC

Contemporary art collage. Businessman standing under heavy pressure. Working conditions. Concept of struggle, failure, success, competition, motivation, concentration, crisis, fear Copy space for ad

Obesity

Novo buys three early-stage obesity assets from Kallyope as investor pressure mounts

September 21, 2026

·

1 min read

·

Tristan Manalac

Symbolic image: Tablets, US Dollar and China - Dependence on the Chinese pharmaceutical industry

China

China plans to transform biotech sector into $522B powerhouse by 2030

September 18, 2026

·

2 min read

·

Annalee Armstrong

The intertwining wires flash in different colors, 3D rendering illustration.

IPO

Electra lights up with $350M IPO for pivotal immune-disease drug development

September 18, 2026

·

1 min read

·

Gabrielle Masson

Bridging the gap connect the path to success together, teamwork or partnership, collaboration or cooperation for winning challenge, businessman connect jigsaw puzzle as the bridge to connect the gap.

Deals

Novo notches up to $1.4B pact with Orbis to develop oral macrocycle cardiometabolic drugs

September 17, 2026

·

2 min read

·